查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
MEA 呼吸道感染治療市場規模和預測、區域佔有率、趨勢和成長機會分析報告涵蓋範圍：按藥物、疾病適應症、給藥途徑、年齡層、配銷通路和國家/地區
市場調查報告書
商品編碼
1463834

MEA 呼吸道感染治療市場規模和預測、區域佔有率、趨勢和成長機會分析報告涵蓋範圍：按藥物、疾病適應症、給藥途徑、年齡層、配銷通路和國家/地區

MEA Respiratory Tract Infection Treatment Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug, Disease Indication, Route of Administration, Age Group, Distribution Channel, and Country
出版日期: | 出版商: The Insight Partners | 英文 201 Pages | 訂單完成後即時交付

價格

MEA呼吸道感染治療市場規模預計將從2023年的20.9億美元成長到2031年的29.7億美元；預計2023年至2031年複合年成長率為4.50%。

治療呼吸道感染的非處方藥產品需求激增 MEA 呼吸道感染治療市場的成長機會

大量消費者尋求針對咳嗽、鼻塞和喉嚨痛等常見呼吸道症狀的便利解決方案。這種方法使沒有​​患有危及生命的疾病的個人能夠密切監測和控制他們的健康。它還允許製造商、藥房和醫療保健提供者使其產品更適合非處方藥 (OTC) 應用，教育消費者進行自我保健實踐，並改善獲得緩解各種症狀的治療選擇的機會。非處方呼吸療法的快速普及凸顯了提高呼吸健康意識、培養自我管理策略和協作醫療生態系統的重要性。透過利用非處方呼吸道產品的日益普及，中東和非洲地區的呼吸道感染治療市場利益相關者可以提高患者參與度，推廣預防性醫療保健措施，並滿足不同人群不斷變化的醫療保健需求。因此，對治療呼吸道感染的非處方藥產品的需求不斷成長，為 MEA 呼吸道感染治療市場帶來了重大機會。

基於藥物的見解

在藥品方面，抗生素細分市場在 2023 年佔據最大的 MEA 呼吸道感染治療市場佔有率。呼吸道感染包括一系列疾病，包括支氣管炎、肺炎和鼻竇炎，通常由細菌病原體引起。

基於疾病適應症的見解

根據疾病跡象，下呼吸道感染細分市場將在 2023 年佔據更大的市場佔有率。通常由細菌、病毒或真菌病原體等引起。

基於給藥途徑的見解

從給藥途徑來看，口服細分市場在MEA呼吸道感染治療市場中佔有較大佔有率；預計同一細分市場在 2023 年至 2031 年期間將出現更高的複合年成長率。經常使用阿莫西林、阿奇黴素或多西環素等口服抗生素來對抗引起呼吸道感染的細菌病原體。

基於年齡層的見解

就年齡層而言，2023年成人細分市場在MEA呼吸道感染治療市場中佔有較大佔有率。兒童呼吸道感染的高盛行率是推動有效治療方案需求的關鍵因素。

基於配銷通路的見解

就配銷通路而言，醫院藥房業務預計將在 2023 年至 2031 年期間佔據重要的市場佔有率。醫院藥房是醫療保健系統的關鍵組成部分；它們在治療需要靜脈或肌肉注射藥物的急性和嚴重呼吸道感染方面尤其發揮著至關重要的作用。

在準備 MEA 呼吸道感染治療市場報告時提到的一些主要一手和二手來源包括杜拜衛生局、沙烏地阿拉伯氣喘計劃、沙烏地阿拉伯胸腔科學會。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：MEA 呼吸道感染治療市場格局

  • 概述
  • PEST分析

第 5 章：MEA 呼吸道感染治療市場 - 主要市場動態

  • MEA 呼吸道感染治療市場 - 主要市場動態
  • 主要市場促進因素
    • 中東呼吸道感染病例不斷增加
    • 提高對呼吸道感染的認知
  • 主要市場限制
    • 缺乏針對呼吸治療的研究
  • 主要市場機會
    • 治療呼吸道感染的非處方藥產品需求激增
  • 未來的趨勢
    • MERS 抗病毒治療的出現
  • 促進因素和限制的影響：

第 6 章：MEA 呼吸道感染治療市場分析

  • MEA 呼吸道感染治療市場收入，2023-2031

第 7 章：MEA 呼吸道感染治療市場分析 - 按藥物

  • 抗生素
  • 非類固醇抗發炎藥
  • 止咳藥
  • 鼻減充血劑

第 8 章：MEA 呼吸道感染治療市場分析 - 依疾病適應症

  • 下呼吸道感染
  • 上呼吸道感染

第 9 章：MEA 呼吸道感染治療市場分析 - 按給藥途徑

  • 口服
  • 注射用

第 10 章：MEA 呼吸道感染治療市場分析 - 按年齡層

  • 兒科
  • 成年人

第 11 章：MEA 呼吸道感染治療市場分析 - 按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 12 章：MEA 呼吸道感染治療市場 - 國家分析

  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • MEA 的其餘部分
    • MEA 的其餘部分

第 13 章：公司簡介

  • Abbott Laboratories
  • Teva Pharmaceutical Industries Ltd
  • Sanofi SA
  • Boehringer Ingelheim International GmbH
  • AstraZeneca Plc
  • Alembic Pharmaceuticals Ltd
  • GSK Plc
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Gulf Pharmaceutical Industries Co

第 14 章：附錄

Product Code: TIPRE00038996

The MEA respiratory tract infection treatment market size is expected to grow from US$ 2.09 billion in 2023 to US$ 2.97 billion by 2031; it is estimated to register a CAGR of 4.50% from 2023 to 2031.

Surge in Demand for OTC Products to Treat Respiratory Infections Opportunity for Growth of MEA Respiratory Tract Infection Treatment Market

A vast number of consumers seek accessible and convenient solutions for common respiratory symptoms such as cough, congestion, and sore throat. This approach empowers individuals who are not suffering from life-threatening diseases to closely monitor and control their health. It also allows manufacturers, pharmacies, and healthcare providers to make their product offerings more suitable for over-the-counter (OTC) applications, educate consumers on self-care practices, and improve access to treatment options providing relief from various symptoms. The burgeoning popularity of OTC respiratory remedies underlines the importance of promoting respiratory health awareness, fostering self-management strategies and a collaborative healthcare ecosystem. By leveraging the rising popularity of OTC respiratory products, the respiratory tract infection treatment market stakeholders in the MEA can enhance patient engagement, promote preventive healthcare measures, and address the evolving healthcare needs of diverse populations. Thus, the increasing demand for OTC products to manage respiratory infections represents a significant opportunity for the MEA respiratory tract infection treatment market.

Drug -Based Insights

In terms of drug, the antibiotics segment held the largest MEA respiratory tract infection treatment market share in 2023. The same is anticipated to register the highest CAGR during 2023-2031. Respiratory tract infections encompass a range of ailments, including bronchitis, pneumonia, and sinusitis, often caused by bacterial pathogens.

Disease Indication -Based Insights

Based on disease indication, the lower respiratory tract infection segment held a larger market share in 2023. It is further anticipated to register a higher CAGR from 2023 to 2031. Lower respiratory tract infections (LRTIs) are infections that affect the lungs and bronchial tubes, typically caused by bacterial, viral, or fungal pathogens, among others.

Route Of Administration -Based Insights

By route of administration, the oral segment held a larger share of the MEA respiratory tract infection treatment market; the same segment is anticipated to register a higher CAGR during 2023-2031. Oral antibiotics such as amoxicillin, azithromycin, or doxycycline are frequently prescribed to combat bacterial pathogens causing respiratory tract infections.

Age Group -Based Insights

In terms of age group, the adult segment held a larger share of the MEA respiratory tract infection treatment market in 2023. The pediatrics segment is anticipated to register a higher CAGR during 2023-2031. The high prevalence of respiratory tract infections among children is a key factor driving the need for effective treatment options.

Distribution Channel -Based Insights

In terms of distribution channel, the hospital pharmacies segment is anticipated to account for a significant market share during 2023-2031. Hospital pharmacies serve as key components of a healthcare system; they particularly play a vital role in the management of acute and severe respiratory tract infections, which require intravenous or intramuscular administration of medications.

A few of the major primary and secondary sources referred to while preparing the report on the MEA respiratory tract infection treatment market are the Dubai Health Authority, Saudi Initiative for Asthma, Saudi Thoracic Society.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. MEA Respiratory Tract Infection Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. MEA Respiratory Tract Infection Treatment Market - Key Market Dynamics

  • 5.1 MEA Respiratory Tract Infection Treatment Market - Key Market Dynamics
  • 5.2 Key Market Drivers
    • 5.2.1 Rising Cases of Respiratory Infections in Middle East
    • 5.2.2 Increasing Awareness Related to Respiratory Tract Infections
  • 5.3 Key Market Restraints
    • 5.3.1 Lack of Research Focused on Respiratory Therapeutics
  • 5.4 Key Market Opportunities
    • 5.4.1 Surge in Demand for OTC Products to Treat Respiratory Infections
  • 5.5 Future Trends
    • 5.5.1 Advent of Antiviral Treatment for MERS
  • 5.6 Impact of Drivers and Restraints:

6. MEA Respiratory Tract Infection Treatment Market Analysis

  • 6.1 MEA Respiratory Tract Infection Treatment Market Revenue (US$ Million), 2023-2031

7. MEA Respiratory Tract Infection Treatment Market Analysis - by Drugs

  • 7.1 Antibiotics
    • 7.1.1 Overview
    • 7.1.2 Antibiotics: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 NSAIDs
    • 7.2.1 Overview
    • 7.2.2 NSAIDs: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Cough Suppressants
    • 7.3.1 Overview
    • 7.3.2 Cough Suppressants: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Nasal Decongestants
    • 7.4.1 Overview
    • 7.4.2 Nasal Decongestants: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

8. MEA Respiratory Tract Infection Treatment Market Analysis - by Disease Indication

  • 8.1 Lower Respiratory Tract Infection
    • 8.1.1 Overview
    • 8.1.2 Lower Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Upper Respiratory Tract Infection
    • 8.2.1 Overview
    • 8.2.2 Upper Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

9. MEA Respiratory Tract Infection Treatment Market Analysis - by Route Of Administration

  • 9.1 Oral
    • 9.1.1 Overview
    • 9.1.2 Oral: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Parenteral
    • 9.2.1 Overview
    • 9.2.2 Parenteral: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

10. MEA Respiratory Tract Infection Treatment Market Analysis - by Age Group

  • 10.1 Pediatrics
    • 10.1.1 Overview
    • 10.1.2 Pediatrics: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Adults
    • 10.2.1 Overview
    • 10.2.2 Adults: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

11. MEA Respiratory Tract Infection Treatment Market Analysis - by Distribution Channel

  • 11.1 Hospital Pharmacies
    • 11.1.1 Overview
    • 11.1.2 Hospital Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Retail Pharmacies
    • 11.2.1 Overview
    • 11.2.2 Retail Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Online Pharmacies
    • 11.3.1 Overview
    • 11.3.2 Online Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12. MEA Respiratory Tract Infection Treatment Market - Country Analysis

  • 12.1 Middle East and Africa
    • 12.1.1 MEA Respiratory Tract Infection Treatment Market Breakdown by Countries
    • 12.1.2 MEA Respiratory Tract Infection Treatment Market Revenue and Forecast and Analysis - by Country
    • 12.1.3 MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2030
      • 12.1.3.1 MEA Respiratory Tract Infection Treatment Market Revenue and Forecast and Analysis - by Country
      • 12.1.3.2 Saudi Arabia
      • 12.1.3.3 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.3.3.1 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs
        • 12.1.3.3.2 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication
        • 12.1.3.3.3 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration
        • 12.1.3.3.4 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group
        • 12.1.3.3.5 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel
      • 12.1.3.4 South Africa
      • 12.1.3.5 South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.3.5.1 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs
        • 12.1.3.5.2 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication
        • 12.1.3.5.3 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration
        • 12.1.3.5.4 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group
        • 12.1.3.5.5 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel
      • 12.1.3.6 UAE
      • 12.1.3.7 UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.3.7.1 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs
        • 12.1.3.7.2 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication
        • 12.1.3.7.3 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration
        • 12.1.3.7.4 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group
        • 12.1.3.7.5 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel
      • 12.1.3.8 Rest of MEA
      • 12.1.3.9 REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.3.9.1 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs
        • 12.1.3.9.2 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication
        • 12.1.3.9.3 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration
        • 12.1.3.9.4 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group
        • 12.1.3.9.5 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel

13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Teva Pharmaceutical Industries Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Sanofi SA
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Boehringer Ingelheim International GmbH
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 AstraZeneca Plc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Alembic Pharmaceuticals Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 GSK Plc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Novartis AG
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 F. Hoffmann-La Roche Ltd
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Gulf Pharmaceutical Industries Co
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. MEA Respiratory Tract Infection Treatment Market Segmentation
  • Table 2. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs
  • Table 3. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication
  • Table 4. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 5. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group
  • Table 6. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 7. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Country
  • Table 8. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs
  • Table 9. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication
  • Table 10. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 11. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group
  • Table 12. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 13. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs
  • Table 14. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication
  • Table 15. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 16. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group
  • Table 17. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 18. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs
  • Table 19. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication
  • Table 20. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 21. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group
  • Table 22. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 23. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs
  • Table 24. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication
  • Table 25. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 26. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group
  • Table 27. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 28. Glossary of Terms, MEA Respiratory Tract Infection Treatment Market

List Of Figures

  • Figure 1. MEA Respiratory Tract Infection Treatment Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. MEA Respiratory Tract Infection Treatment Market Revenue (US$ Million), 2023-2031
  • Figure 5. MEA Respiratory Tract Infection Treatment Market Share (%) - by Drugs, 2023 and 2031
  • Figure 6. Antibiotics: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. NSAIDs: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Cough Suppressants: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Nasal Decongestants: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. MEA Respiratory Tract Infection Treatment Market Share (%) - by Disease Indication, 2023 and 2031
  • Figure 11. Lower Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Upper Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. MEA Respiratory Tract Infection Treatment Market Share (%) - by Route Of Administration, 2023 and 2031
  • Figure 14. Oral: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Parenteral: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. MEA Respiratory Tract Infection Treatment Market Share (%) - by Age Group, 2023 and 2031
  • Figure 17. Pediatrics: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Adults: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. MEA Respiratory Tract Infection Treatment Market Share (%) - by Distribution Channel, 2023 and 2031
  • Figure 20. Hospital Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Retail Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Online Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. MEA Respiratory Tract Infection Treatment Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 24. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 25. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)